About Aarti Drugs Ltd

Established in 1984, Aarti Drugs Ltd. is part of the USD 900 million Aarti Group of Industries. The company specializes in the production of Active Pharmaceutical Ingredients (API), pharmaceutical intermediates, specialty chemicals, and dosage forms. With a strong R&D division in Tarapur, Maharashtra, Aarti Drugs offers a wide range of products, including Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, and others. It is a well-known brand in the sector and makes a substantial contribution to both the domestic and global markets. The Aarti Drugs Ltd share price has been trending upward recently, reflecting positive market sentiment towards the company. To get the Aarti Drugs share price live, you can check financial news websites or stock market apps that provide real-time updates. Investors looking for detailed information can view the Aarti Drugs share price NSE on the National Stock Exchange’s website for the most accurate figures.

History of Aarti Drugs Ltd

Aarti Drugs Ltd. was founded in 1984 and, since then, has developed into a major player in the pharmaceutical industry. Over time, it has added a wide range of APIs, drug intermediates, and specialty chemicals to its product portfolio. Driven by a strong R&D base and strategic growth, the company has become one of the leading producers of various pharmaceutical compounds in the world.

Key Personnel of Aarti Drugs Ltd

Shri Chandrakant V. Gogri, Chairman Emeritus and CEO.
Shri Prakash M. Patil, Chairman, Managing Director, and CEO
Shri Rashesh C. Gogri, Managing Director
Shri Adhish P. Patil, Chief Financial Officer and Chief Operating Officer.

Business Segments of Aarti Drugs Ltd

Aarti Drugs Ltd. is involved in multiple significant business segments.

Active Pharmaceutical Ingredients: Produces different APIs like Ofloxacin, Metronidazole, Ciprofloxacin Hydrochloride, Metformin HCL, and Ketoconazole.
Pharma Intermediates: Manufacturing of intermediaries for use in medication combinations.
Specialty Chemicals: Manufacturing substances such as methyl nitrate and benzene sulphonyl chloride.
Formulations: The company manufactures a range of drug formulations through Pinnacle Life Science Private Limited, a subsidiary.

Subsidiaries of Aarti Drugs Ltd

Aarti Drugs Ltd. has multiple subsidiaries in order to expand its manufacturing and market penetration. These include:

Pinnacle Life Science Private Limited: A wholly-owned subsidiary of Aarti Drugs that extends the company's core competencies through the production of formulations.
Aarti Healthcare Ltd.: This subsidiary adds diversity to the company's offering by specializing in a range of healthcare products.

Corporate Actions of Aarti Drugs Ltd

Dividend Announcement: In order to compensate its shareholders, Aarti Drugs Ltd. periodically announces dividends. Its financial reports include information on record dates and dividend payouts.
Bonuses: Through alignment with outstanding company performance as well as the creation of a large pool of the lump sum, the director gave bonus stocks to the current shareholders.
Split: For great reasons of liquidity and low price cost, Aarti Drugs Ltd. chooses to make its shares divisible by changing the total number as well as the price.
Acquisitions and mergers: The company, in obtaining the product variety as well as the market share, does it through appropriate acquisitions and mergers.

Aarti Drugs Ltd

AARTIDRUGS Share Price